Cargando…
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
BACKGROUND: Pseudomyogenic hemangioendothelioma (PMHE) is a rare endothelial neoplasm that involves the bones in only 14% of all cases. The optimal treatment strategy has not been established. We herein report a case of primary PMHE in which denosumab treatment showed activity in both imaging studie...
Autores principales: | Otani, Shinya, Nakayama, Robert, Sekita, Tetsuya, Hirozane, Toru, Asano, Naofumi, Nishimoto, Kazumasa, Sasaki, Aya, Okita, Hajime, Morioka, Hideo, Nakamura, Masaya, Matsumoto, Morio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724307/ https://www.ncbi.nlm.nih.gov/pubmed/31481040 http://dx.doi.org/10.1186/s12885-019-6072-8 |
Ejemplares similares
-
Clinicopathological study of pseudomyogenic hemangioendothelioma
por: Yang, Ningning, et al.
Publicado: (2023) -
Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma
por: Joseph, Jason, et al.
Publicado: (2015) -
A Case of Pseudomyogenic Hemangioendothelioma of the Lower Extremity
por: Choi, Myoung Eun, et al.
Publicado: (2020) -
Pseudomyogenic hemangioendothelioma: A misleading vascular tumor
por: Sassi, Farah, et al.
Publicado: (2022) -
Preservation of the Epiphysis and Growth Plate in the Surgical Management of Femoral Osteosarcoma in a Skeletally Immature Patient by Intercalary Resection and Biological Reconstruction: A Case Report
por: Yoda, Yuhei, et al.
Publicado: (2019)